Immunohistochemical study of inducible nitric oxide synthase in skin cancers

M Kagoura1, C Matsui, M Toyoda

  • 1Department of Dermatology, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan. kago@ms.toyama-mpu.ac.jp

Abstract

Insights

Inducible nitric oxide synthase (iNOS) expression varies across skin cancers. Higher iNOS levels in squamous cell carcinoma and metastatic tumors suggest a link to tumor cell proliferation and diverse biological behaviors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Nitric oxide (NO) is synthesized from L-arginine by NO synthase (NOS).
  • Increased expression of inducible NOS (iNOS), a calcium-independent isoform, is linked to inflammation and cancer.
  • iNOS plays a role in various pathological processes.

Purpose of the Study:

  • To investigate the expression of iNOS in different types of skin tumors.
  • To correlate iNOS expression with tumor characteristics and behavior.

Main Methods:

  • Immunohistochemistry was used to detect iNOS expression.
  • The study analyzed basal cell carcinoma (BCC), Bowen's disease, squamous cell carcinoma (SCC), extramammary Paget's disease (EPD), and metastatic skin tumors.

Main Results:

  • iNOS was rarely detected in BCC.
  • Weak iNOS expression was observed in Bowen's disease.
  • SCC showed higher iNOS positivity than Bowen's disease.
  • Metastatic cancers frequently expressed iNOS, with heterogeneous staining in poorly differentiated types.

Conclusions:

  • iNOS expression may correlate with tumor cell proliferation.
  • Heterogeneous iNOS distribution might indicate diverse biological behavior in tumor cells.

Related Concept Videos